Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Time between redetachment and retinectomy in eyes with proliferative vitreoretinopathy impacts outcomes
  • Inherited Retinal Disease

Time between redetachment and retinectomy in eyes with proliferative vitreoretinopathy impacts outcomes

Ophthalmology 360

Several modifiable factors are associated with good visual acuity (VA) following repair of rhegmatogenous retinal detachments (RD) with proliferative vitreoretinopathy (PVR) undergoing retinectomy, according to a study.

In this interventional, retrospective, case-control study, 345 eyes that underwent retinectomy during repair of RD with PVR, were included. A good VA cohort of 62 eyes with a final VA ≥20/70 (good VA cohort) and a poor VA cohort of age- and gender-matched eyes with VA <20/70 were identified.

There was a mean final logMAR VA of 0.32 [Snellen 20/42] and 1.54 [Snellen 20/693] in the good VA cohort and poor VA cohort, respectively.

The following were significant predictors of good vision:

-Smaller initial RD size
-Fewer surgeries
-Shorter time between recurrent RD diagnosis and subsequent surgeries
-Better pre-operative VA
-Pseudophakia at final visit

Reference
Israilevich RN, Starr MR, Mahmoudzadeh R, et al. Factors Associated with Good Visual Acuity Outcomes After Retinectomy in Eyes with Proliferative Vitreoretinopathy. Am J Ophthalmol. 2022;S0002-9394(22)00096-4. doi: 10.1016/j.ajo.2022.02.028. Epub ahead of print. PMID: 35288070.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

  • Inherited Retinal Disease

Limited myopia progression in CSNB patients may guide treatment approaches

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon